Is hepatitis C direct-acting antiviral therapy a risk...

  • Main
  • 2020 / 7
  • Is hepatitis C direct-acting antiviral therapy a risk...

Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations

Delgado-Martínez, Carolina, Gómez-Rubio, Mariano, Gómez-Domínguez, Cecilia
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Annals of Hepatology
DOI:
10.1016/j.aohep.2020.05.007
Date:
July, 2020
File:
PDF, 2.08 MB
2020
Conversion to is in progress
Conversion to is failed